Filter by Categories
Ethereum Ethereum ETF

Crypto Crisp: Your Move, Gary Gensler

This is the final week before the U.S. Securities and Exchange Commission (SEC) must make a decision on the Ethereum spot ETF. Given the potentially transformative impact of an Ethereum spot ETF, the next two weeks are critical for the entire industry. There have been several developments regarding this matter in the recent weeks.
2024-05-13
<a href="https://stenoresearch.com/author/madseberhardt/" target="_self">Mads Eberhardt</a>

Mads Eberhardt

0

We have entered the week before the U.S. Securities and Exchange Commission (SEC) must decide on VanEck’s Ethereum spot ETF application, with a decision due next Thursday, May 23. It is expected that the outcome for this application will set a precedent for all the other Ethereum ETF applications.

This issue of Crypto Crisp focuses extensively on the Ethereum spot ETF. We delve into the current knowledge surrounding this crucial upcoming decision, which will have far-reaching effects not only on Ethereum but on the entire market as well. For months, we have posited that the introduction of an Ethereum spot ETF will turn into a resounding success, akin to the recently launched U.S.-based Bitcoin spot ETFs. We are excited to introduce a new segment in Crypto Crisp titled ‘An ETF a Day Keeps the Doctor Away’. This feature will make a one-time appearance, temporarily replacing ‘Three In a Row’, which will return next week.

An ETF a Day Keeps the Doctor Away

We maintain our forecast that there is a 60% chance the Ethereum ETF will launch this year, with 30% likelihood of approval next week, as recently discussed in Crypto Moves #23.

This is the final week before the U.S. Securities and Exchange Commission (SEC) must make a decision on the Ethereum spot ETF. Given the potentially transformative impact of an Ethereum spot ETF, the next two weeks are critical for the entire industry. There have been several developments regarding this matter in the recent weeks.

Get access / Login

0 Comments

STENO RESEARCH IS JOINING REAL VISION

From July 2025, Steno Research is joining Real Vision to create the ultimate macro research product for you!

As a subscriber, this means the following:

Yearly subscriber: For legal reasons, we cannot transfer your pre-paid subscription directly. You need to register with Real Vision and then we’ll transfer your pre-paid subscription quickly afterwards. Simply go to https://www.realvision.com/free and sign up - and then we’ll take care of the rest! We will shut down service of Steno Research on July 31st, so be sure to make the transfer to keep receiving our content.

Already a RV subscriber?
Please check that you are using the same e-mail. If yes, you don't need to do anything. If not, please contact [email protected].

Monthly subscriber: Your current monthly subscription with Steno Research will end during July (31st at the latest). To continue accessing our research (and more), you’ll need to sign up for a Real Vision membership. Check out your options on: https://www.realvision.com/pricing

For Institutional Clients:
- Your access has been moved to our new institutional offering at NowcastIQ.com
- If you haven’t been moved already, please contact [email protected]